You are spot on there. Great to have your talent here btw followed you for years.
At 10c we are valued at 60/80m pre and post Cynata acquisition. This will take us to the phase 1 Trial. Couple this with the 34 Journals that all suggest MCA's have high efficacy etc. 34 JOURNALS!!!
We are highly undervalued here. Sure the trials are a while away but by then I can say we wont be here.
The fact that 34 Journals suggest they are safe is HUGE. There is sure to be large interest in this one.
Trials will be fast tracked too with the Wisconsin outfit. That is what washer and macdonald are here to do. have you seen ISN?
This whole thing revolves around Cynata and imo the 34 articles saying they are unequivocally safe (virtually). Look at CDI among other stem cell companies.
This gets funding and 12/18 months into things we may be worth 200m. After that who knows. I do know that the WARF have a very good reputation.
ECQ Price at posting:
2.9¢ Sentiment: Buy Disclosure: Held